Oral ivermectin versus malathion lotion for difficult-to-treat head lice

Area of Science:

• Parasitology
• Dermatology
• Clinical Trials

Background:

• Head-lice infestation is a common global health issue, particularly affecting children.
• Insecticide resistance, especially to pyrethroids, compromises the effectiveness of standard topical treatments.
• Alternative treatments for head lice require robust clinical evaluation.

Purpose of the Study:

• To compare the efficacy of oral ivermectin versus topical malathion lotion for treating head-lice infestation.
• To evaluate treatment outcomes in patients with persistent lice after prior topical insecticide use.

Main Methods:

• A multicenter, randomized, double-blind, controlled trial was conducted.
• Participants received either oral ivermectin (400 microg/kg) or 0.5% malathion lotion, administered on days 1 and 8.
• Infestation was confirmed by fine-toothed combing, with the primary endpoint being lice absence on day 15.

Main Results:

• Oral ivermectin achieved a significantly higher lice-free rate (95.2%) compared to malathion lotion (85.0%) in the intention-to-treat analysis (P<0.001).
• Per-protocol analysis also showed superior efficacy for ivermectin (97.1%) versus malathion (89.8%) (P=0.002).
• Adverse event frequencies were comparable between the ivermectin and malathion treatment groups.

Conclusions:

• Oral ivermectin demonstrates superior efficacy for difficult-to-treat head-lice infestations compared to topical malathion.
• Ivermectin represents a viable alternative treatment option for recalcitrant cases of head lice.
• The study provides strong evidence supporting the use of oral ivermectin in pediatric head-lice management.